Black Diamond Therapeutics Insider Trades
NASDAQ: BDTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Black Diamond Therapeutics insider activity
Over the last 12 months, Black Diamond Therapeutics insiders reported 8 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Behbahani Ali (Director) reporting a transaction in 7,707 shares at $1.93 on Sep 18, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BDTX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
BDTX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 18, 2026 | Raman PrakashDirector | Award | 6,801 | $13.13K | Form 4 |
| Sep 18, 2026 | Behbahani AliDirector | Award | 7,707 | $14.87K | Form 4 |
| Jun 19, 2026 | Raman PrakashDirector | Award | 7,907 | $13.13K | Form 4 |
| Jun 19, 2026 | Behbahani AliDirector | Award | 8,961 | $14.88K | Form 4 |
| Mar 20, 2026 | Raman PrakashDirector | Award | 6,105 | $13.13K | Form 4 |
| Mar 20, 2026 | Behbahani AliDirector | Award | 6,919 | $14.88K | Form 4 |
| Dec 12, 2025 | Raman PrakashDirector | Award | 4,665 | $12.88K | Form 4 |
| Dec 12, 2025 | Behbahani AliDirector | Award | 5,208 | $14.37K | Form 4 |
| Sep 19, 2025 | Raman PrakashDirector | Award | 3,843 | $12.87K | Form 4 |
| Sep 19, 2025 | Behbahani AliDirector | Award | 4,291 | $14.37K | Form 4 |
| Jun 20, 2025 | Raman PrakashDirector | Award | 5,526 | $12.88K | Form 4 |
| Jun 20, 2025 | Behbahani AliDirector | Award | 6,170 | $14.38K | Form 4 |
| Mar 21, 2025 | Raman PrakashDirector | Award | 6,848 | $12.87K | Form 4 |
| Mar 21, 2025 | Behbahani AliDirector | Award | 7,646 | $14.37K | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V & BB BIOTECH AG10% Owner | Sale | 500,000 | $1.06M | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V & BB BIOTECH AG10% Owner | Sale | 584,292 | $1.14M | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V & BB BIOTECH AG10% Owner | Sale | 400,000 | $837.16K | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V & BB BIOTECH AG10% Owner | Sale | 2,000,000 | $4.00M | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V & BB BIOTECH AG10% Owner | Sale | 1,000,000 | $2.31M | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V & BB BIOTECH AG10% Owner | Sale | 300,000 | $582.90K | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V & BB BIOTECH AG10% Owner | Sale | 1,000,000 | $2.07M | Form 4 |
| Jan 30, 2025 | Hatzis-Schoch BrentSEE REMARKS | Award | 75,000 | — | Form 4 |
| Jan 30, 2025 | Buck ElizabethCHIEF SCIENTIFIC OFFICER | Award | 75,000 | — | Form 4 |
| Jan 30, 2025 | Yurasov SergeyCHIEF MEDICAL OFFICER | Award | 75,000 | — | Form 4 |
| Jan 30, 2025 | Velleca Mark A.PRESIDENT & CEO | Award | 75,000 | — | Form 4 |
| Jan 30, 2025 | Jones ErikaSEE REMARKS | Award | 75,000 | — | Form 4 |
| Dec 13, 2024 | Raman PrakashDirector | Award | 5,150 | $12.88K | Form 4 |
| Dec 13, 2024 | Campbell ShannonDirector | Award | 4,500 | $11.25K | Form 4 |
| Dec 13, 2024 | Behbahani AliDirector | Award | 5,750 | $14.38K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4